Delaware State University and the Nemours Center for Cancer and Blood Disorders received a $10.2 million grant from the National Institutes of Health to support genetic research on sickle cell disease. Nemours will use $8.4 million for research training, data recording, clinical trials and modification of a pediatric screening tool, while DSU will use $1.8 million for studies focusing on hematopoietic stem cell production and the editing of genes to fix hemoglobin.

Related Summaries